Helix BioPharma Balance Sheet
Helix BioPharma's total assets for Q2 2026 were C$18.52M, a decrease of -2.84% from the previous quarter. TSE:HBP total liabilities were C$3.16M for the fiscal quarter, a 5.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.